Related references
Note: Only part of the references are listed.Disabling the Protease DDI2 Attenuates the Transcriptional Activity of NRF1 and Potentiates Proteasome Inhibitor Cytotoxicity
Amy Northrop et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation
Alessia Garufi et al.
BIOMOLECULES (2020)
Regulation of the Expression of DAPK1 by SUMO Pathway
Qingshui Wang et al.
BIOMOLECULES (2019)
Nrf1-mediated transcriptional regulation of the proteasome requires a functional TIP60 complex
Janakiram R. Vangala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection
Hai Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
BET Proteins as Targets for Anticancer Treatment
Anastasios Stathis et al.
CANCER DISCOVERY (2018)
SnapShot: TCGA-Analyzed Tumors
Amy Blum et al.
CELL (2018)
The Unfolded Protein Response and Cell Fate Control
Claudio Hetz et al.
MOLECULAR CELL (2018)
Oncogenic addiction to high 26S proteasome level
Peter Tsvetkov et al.
CELL DEATH & DISEASE (2018)
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
Alexandra B. Keenan et al.
CELL SYSTEMS (2018)
Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer
Javier Perez-Pena et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Vasileios Stathias et al.
NATURE COMMUNICATIONS (2018)
Positioning of proteasome inhibitors in therapy of solid malignancies
Margot S. F. Roeten et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
Takao Fujisawa et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The Logic of the 26S Proteasome
Galen Andrew Collins et al.
CELL (2017)
Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation
Emily S. Weyburne et al.
CELL CHEMICAL BIOLOGY (2017)
Induction of autophagy by the MG-132 proteasome inhibitor is associated with endoplasmic reticulum stress in MCF-7 cells
Wenhua Bao et al.
MOLECULAR MEDICINE REPORTS (2016)
Nrf1 can be processed and activated in a proteasome-independent manner
Janakiram R. Vangala et al.
CURRENT BIOLOGY (2016)
Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy
Insoon Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells
Yonghua Shi et al.
ONCOTARGET (2016)
Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis
Hao Wang et al.
SCIENTIFIC REPORTS (2016)
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
Nicolas J. Lehrbach et al.
ELIFE (2016)
The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction
Shun Koizumi et al.
ELIFE (2016)
Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
David C. Smith et al.
INVESTIGATIONAL NEW DRUGS (2015)
When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock Response
Shardule P. Shah et al.
MOLECULAR CANCER RESEARCH (2015)
Regulation of PSMB5 Protein and β Subunits of Mammalian Proteasome by Constitutively Activated Signal Transducer and Activator of Transcription 3 ( STAT3)
Janakiram Reddy Vangala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma
Lenka Kubiczkova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition
Senthil K. Radhakrishnan et al.
ELIFE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Molecular Architecture and Assembly of the Eukaryotic Proteasome
Robert J. Tomko et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
ER stress-induced cell death mechanisms
Renata Sano et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Two new sesquiterpenoids from the rhizomes of Nardostachys jatamansi
K. Rekha et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2013)
Proteasome inhibitors in mantle cell lymphoma
Beata Holkova et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production
Barbara Iovine et al.
CANCER LETTERS (2012)
Stereoselective Total Synthesis of (+)-Oploxyne A, (-)-Oploxyne B, and Their C-10 Epimers and Structure Revision of Natural Oploxyne B
J. S. Yadav et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Dual Regulation of the Transcriptional Activity of Nrf1 by β-TrCP- and Hrd1-Dependent Degradation Mechanisms
Yoshiki Tsuchiya et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Transcription Factor Nrf1 Mediates the Proteasome Recovery Pathway after Proteasome Inhibition in Mammalian Cells
Senthil K. Radhakrishnan et al.
MOLECULAR CELL (2010)
Proteasomal Degradation Is Transcriptionally Controlled by TCF11 via an ERAD-Dependent Feedback Loop
Janos Steffen et al.
MOLECULAR CELL (2010)
Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
K. Zhu et al.
ONCOGENE (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
The relationship among tumor architecture, pharmacokinetics, pharmacodynamics, and efficacy of bortezomib in mouse xenograft models
Mark J. Williamson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability
Wen-Xing Ding et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Aggresome disruption: A novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells
ST Nawrocki et al.
CANCER RESEARCH (2006)
The PPAR-γ agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines
SK Radhakrishnan et al.
CELL CYCLE (2005)
Share Paper
